Uncategorized
NovaBay reports $4 million quarterly loss
NovaBay Pharmaceuticals announced a $4 million net loss in the first quarter of 2017 compared with a net loss of $5.1 million in the same quarter of last year. Research and development costs declined from $0.9 million in 2016 to $0.1 million this quarter, while sales and marketing expenses increased from $3.1 million to $3.7 million, according to a press release.